ValuEngine lowered shares of Israel Chemicals (NYSE:ICL) from a buy rating to a hold rating in a research report report published on Saturday, ValuEngine reports.

A number of other equities research analysts have also recently issued reports on ICL. Zacks Investment Research cut shares of Israel Chemicals from a buy rating to a hold rating in a research report on Wednesday, April 10th. Stephens assumed coverage on shares of Israel Chemicals in a research report on Tuesday, March 12th. They set an overweight rating for the company. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $5.94.

Shares of Israel Chemicals stock opened at $5.02 on Friday. The stock has a market cap of $6.51 billion, a P/E ratio of 13.57, a PEG ratio of 1.25 and a beta of 0.83. The company has a quick ratio of 0.79, a current ratio of 1.43 and a debt-to-equity ratio of 0.51. Israel Chemicals has a 12-month low of $4.48 and a 12-month high of $6.90.

Israel Chemicals (NYSE:ICL) last announced its earnings results on Tuesday, May 7th. The basic materials company reported $0.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.02. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Israel Chemicals had a net margin of 8.10% and a return on equity of 13.33%. The firm’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter last year, the company posted $0.08 EPS. As a group, equities research analysts forecast that Israel Chemicals will post 0.42 EPS for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the business. Bank of America Corp DE increased its position in Israel Chemicals by 190.7% in the 4th quarter. Bank of America Corp DE now owns 539,969 shares of the basic materials company’s stock valued at $3,057,000 after acquiring an additional 354,192 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in Israel Chemicals in the 4th quarter valued at about $754,000. Van ECK Associates Corp increased its position in Israel Chemicals by 2.5% in the 4th quarter. Van ECK Associates Corp now owns 1,959,971 shares of the basic materials company’s stock valued at $11,093,000 after acquiring an additional 48,603 shares in the last quarter. Bank of Montreal Can increased its position in Israel Chemicals by 89.3% in the 4th quarter. Bank of Montreal Can now owns 379,237 shares of the basic materials company’s stock valued at $2,146,000 after acquiring an additional 178,870 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its position in Israel Chemicals by 1.0% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,982,567 shares of the basic materials company’s stock valued at $11,955,000 after acquiring an additional 19,052 shares in the last quarter. Hedge funds and other institutional investors own 8.30% of the company’s stock.

About Israel Chemicals

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.

Featured Article: Equity Income

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.